Global BioDiagnostics logo — Innovating accessible and swift diagnostic solutions for tub...

Global BioDiagnostics

Innovating accessible and swift diagnostic solutions for tuberculosis since 2009.

Founded 2009 Series A Total: $3.22M Health Care

General Information

Company Name Global BioDiagnostics
Founded Year 2009
Industries Health Care
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with Global BioDiagnostics. To contact Global BioDiagnostics, visit globalbiodiagnostics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Global BioDiagnostics compare?

A PDF of Global BioDiagnostics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Global BioDiagnostics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Global BioDiagnostics

Global BioDiagnostics is a biotechnology startup focused on revolutionizing tuberculosis diagnosis since 2009. Their slogan, "Innovating accessible and swift diagnostic solutions for tuberculosis since 2009," embodies their commitment to developing quick, affordable, and user-friendly Point-of-Care tests for active tuberculosis. The company is headquartered in Temple, Texas and operates within the Health Care industry. Notably, they secured a $1.25M Series A investment on 20 March 2015, with funding from Innovate Angel Funds and Turnstone Capital Management. This investment underscores the recognition and support from prominent venture capital firms for Global BioDiagnostics' groundbreaking approach to addressing crucial healthcare challenges.

Business keywords: startup, diagnostics, tuberculosis, Point-of-Care test, innovation, affordable, user-friendly, Texas, global health, rapid diagnostics

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series A $1.25M 2
Innovate Angel Funds, Turnstone Capital Management
20 Mar 2015
Venture Round $1.97M -
03 Feb 2015
Equity Crowdfunding Undisclosed -
31 May 2012

Global BioDiagnostics Alternatives & Competitors

View All Alternatives
Global BioDiagnostics vs

Pioneering a new era in tuberculosis diagnostics with a rapid, user-friendly test replacing century-...

Series A
Biotechnology, Health Care
Global BioDiagnostics vs

Expertly engineered, affordable solutions for challenging point-of-care needs in diverse global land...

Grant
0-1 employees
Biotechnology, Health Care
Global BioDiagnostics vs

Empowering rapid and accurate decisions for ischemic cardiovascular emergencies with an advanced dia...

Pre-Seed
11-50 employees
Biotechnology, Health Care

FAQ About Global BioDiagnostics

Innovating accessible and swift diagnostic solutions for tuberculosis since 2009.
Global BioDiagnostics was founded in 2009.
Global BioDiagnostics operates in Health Care. Its work centres on startup, diagnostics, tuberculosis and Point-of-Care test.
Global BioDiagnostics has completed 3 funding rounds, raising a total of $3.22M. The latest funding stage is Series A.
Top alternatives and competitors to Global BioDiagnostics include TB Biosciences, ZYOMYX, Cor.Sync, Sami, FABPulous. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Global BioDiagnostics and TB Biosciences are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Global BioDiagnostics, https://bouncewatch.com/company/global-biodiagnostics, updated 27 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes